Senseonics (NYSE:SENS) Given “Buy” Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Senseonics (NYSE:SENS) in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have a $2.00 price objective on the stock. HC Wainwright also issued estimates for Senseonics’ Q3 2024 earnings at ($0.04) EPS, Q4 2024 earnings at ($0.04) EPS, FY2024 earnings at ($0.14) EPS and FY2025 earnings at ($0.09) EPS.

Separately, StockNews.com initiated coverage on Senseonics in a research note on Monday, August 12th. They issued a sell rating for the company.

Senseonics Stock Performance

Shares of SENS opened at $0.41 on Wednesday. Senseonics has a one year low of $0.37 and a one year high of $0.75. The business has a fifty day moving average of $0.41 and a 200 day moving average of $0.49. The company has a debt-to-equity ratio of 1.79, a current ratio of 3.96 and a quick ratio of 3.70. The firm has a market capitalization of $221.08 million, a P/E ratio of -2.95 and a beta of 0.82.

Senseonics (NYSE:SENS) last announced its earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative net margin of 335.15% and a negative return on equity of 225.98%. The company had revenue of $4.87 million during the quarter, compared to analyst estimates of $4.86 million. As a group, sell-side analysts anticipate that Senseonics will post -0.12 EPS for the current year.

Hedge Funds Weigh In On Senseonics

A number of hedge funds have recently modified their holdings of the company. State Board of Administration of Florida Retirement System purchased a new position in shares of Senseonics during the 1st quarter valued at $91,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Senseonics by 30.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after acquiring an additional 211,128 shares during the period. Virtu Financial LLC purchased a new position in shares of Senseonics in the first quarter valued at about $162,000. Vanguard Group Inc. lifted its position in shares of Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after acquiring an additional 155,715 shares in the last quarter. Finally, RPO LLC bought a new position in shares of Senseonics in the fourth quarter worth about $37,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.